These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2363298)

  • 1. Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).
    Fujisawa Y; Kuroda S; Van Eerd PM; Schellekens H; Kakinuma A
    Vaccine; 1990 Jun; 8(3):192-8. PubMed ID: 2363298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).
    Kuroda S; Fujisawa Y; Iino S; Akahane Y; Suzuki H
    Vaccine; 1991 Mar; 9(3):163-9. PubMed ID: 1828318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a new type of yeast-derived hepatitis B vaccine consisting of M (pre-S2 + S) protein particles.
    Hazama M; Takaoki M; Ohfune K; Hinuma S; Fujisawa Y
    Vaccine; 1989 Dec; 7(6):567-73. PubMed ID: 2532813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination of haemodialysis patients: randomized controlled trial comparing plasma-derived vaccine with and without pre-S2 antigen.
    Smit-Leijs MB; Kramer P; Heijtink RA; Hop WC; Schalm SW
    Eur J Clin Invest; 1990 Oct; 20(5):540-5. PubMed ID: 2124986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibody responses in human being to pre-S2 and related hepatitis B virus-envelope antigens in vivo and in vitro].
    Ogata M; Ishikawa H; Kato Y; Honta S; Yoshida H; Yasuda H; Ohto H; Watanabe N
    Rinsho Byori; 1991 Jan; 39(1):3-13. PubMed ID: 1826138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful postexposure vaccination against hepatitis B in chimpanzees.
    Iwarson S; Wahl M; Ruttimann E; Snoy P; Seto B; Gerety RJ
    J Med Virol; 1988 Aug; 25(4):433-9. PubMed ID: 3171558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.
    Iwarson S; Tabor E; Thomas HC; Goodall A; Waters J; Snoy P; Shih JW; Gerety RJ
    J Med Virol; 1985 May; 16(1):89-96. PubMed ID: 2413167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens.
    Miskovsky E; Gershman K; Clements ML; Cupps T; Calandra G; Hesley T; Ioli V; Ellis R; Kniskern P; Miller W
    Vaccine; 1991 May; 9(5):346-50. PubMed ID: 1872019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization.
    Coursaget P; Adamowicz P; Bourdil C; Yvonnet B; Buisson Y; Barrès JL; Saliou P; Chiron JP; Mar ID
    Vaccine; 1988 Aug; 6(4):357-61. PubMed ID: 2973189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
    Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine.
    Prince AM; Brotman B; Purcell RH; Gerin JL
    J Med Virol; 1985 Apr; 15(4):399-419. PubMed ID: 3156961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.
    Davis HL; McCluskie MJ; Gerin JL; Purcell RH
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7213-8. PubMed ID: 8692971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenicity of a hepatitis B vaccine obtained by genetic recombination and containing products of S and pre-S2 genes].
    Coursaget P; Yvonnet B; Anthonioz P; Chotard J; Bourdil C; Adamowicz P; Tron F; Girard M
    Presse Med; 1988 Jun; 17(22):1150-1. PubMed ID: 2969536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products.
    Pride MW; Bailey CR; Muchmore E; Thanavala Y
    Vaccine; 1998 Apr; 16(6):543-50. PubMed ID: 9569463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein.
    Yamada T; Iwabuki H; Kanno T; Tanaka H; Kawai T; Fukuda H; Kondo A; Seno M; Tanizawa K; Kuroda S
    Vaccine; 2001 Apr; 19(23-24):3154-63. PubMed ID: 11312011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociated antibody responses to the S and pre-S2 regions of the hepatitis B virus after vaccination in hemophiliacs.
    Zanetti A; Tanzi E; Mannucci PM
    J Med Virol; 1989 Jul; 28(3):156-8. PubMed ID: 2526861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
    Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
    Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.